Massachusetts Financial Services’s Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A BSX.PRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-503,246
| Closed | -$60.9M | – | 884 |
|
|
2023
Q1 | $60.9M | Buy |
503,246
+19,685
| +4% | +$2.38M | 0.02% | 413 |
|
|
2022
Q4 | $55.5M | Hold |
483,561
| – | – | 0.02% | 420 |
|
|
2022
Q3 | $48.9M | Sell |
483,561
-686
| -0.1% | -$69.4K | 0.02% | 442 |
|
|
2022
Q2 | $49.1M | Buy |
484,247
+18,660
| +4% | +$1.89M | 0.02% | 454 |
|
|
2022
Q1 | $54.2M | Buy |
465,587
+15
| +0% | +$1.75K | 0.02% | 467 |
|
|
2021
Q4 | $53.4M | Buy |
+465,572
| New | +$53.4M | 0.01% | 488 |
|
|
2020
Q4 | – | Sell |
-316,463
| Closed | -$35.4M | – | 933 |
|
|
2020
Q3 | $35.4M | Sell |
316,463
-1,982
| -0.6% | -$222K | 0.01% | 478 |
|
|
2020
Q2 | $33.3M | Buy |
+318,445
| New | +$33.3M | 0.01% | 483 |
|